PY 5/23/22 PY 5/23/22 Ab Initio talks about product development strategy at ARCS 2022 Read More PY 5/23/22 PY 5/23/22 Ab Initio at ARCS 2022 Read More PY 5/5/22 PY 5/5/22 Ab Initio Pharma and Coleus to give podium on fast-track to phase 1 at RDD2022 Read More PY 5/2/22 PY 5/2/22 Ab Initio Partners with OzUK to offer MDISprint - bench to clinic MDI services Read More PY 5/2/22 PY 5/2/22 Ab Initio CSO, Dr Hui Xin Ong, to give RDD podium on preclinical tools Read More PY 4/26/22 PY 4/26/22 Meet the Ab Initio Team in person at RDD2022 Read More Marcus Chan 4/14/22 Marcus Chan 4/14/22 Meet Team Abinitio Pharma Read More Marcus Chan 12/24/21 Marcus Chan 12/24/21 Merry Christmas Read More PY 12/11/21 PY 12/11/21 Ab Initio's Chief Scientific Officer recognised for significant accomplishments within the field Read More PY 11/25/21 PY 11/25/21 Learn how Ab Initio is helping start-ups translate therapeutics to the clinic Read More PY 11/1/21 PY 11/1/21 Ab Initio appoints new COO & Head of Manufacturing Read More PY 10/29/21 PY 10/29/21 Ab Initio CSO interviewed by Cosmos Magazine Read More PY 3/29/21 PY 3/29/21 Ab Initio listed on TIA's Pipeline Navigator Read More PY 3/26/21 PY 3/26/21 Ab Initio continues to grow….meet our team! Ab Initio continues to grow….meet our team! Read More PY 2/18/21 PY 2/18/21 Ab Initio's new manufacturing plant nears completion Read More Marcus Chan 2/12/21 Marcus Chan 2/12/21 Ab Initio Pharma wishes Everyone a Healthy, Happy & Prosperous Lunar New Year! Read More Marcus Chan 1/29/21 Marcus Chan 1/29/21 Ab Initio Pharma partners with Consumer Healthcare Company VBreathe. Read More Marcus Chan 1/4/21 Marcus Chan 1/4/21 Ab Initio connects to the Interwebs! Read More PY 1/1/21 PY 1/1/21 Ab Initio Pharma wishes all its clients a COVID safe New Years Celebration and we look forward to working with you in 2021 Read More Marcus Chan 7/9/20 Marcus Chan 7/9/20 University to spin out manufacturing pharmaceuticals company Read More Newer Posts
PY 5/5/22 PY 5/5/22 Ab Initio Pharma and Coleus to give podium on fast-track to phase 1 at RDD2022 Read More
PY 5/2/22 PY 5/2/22 Ab Initio Partners with OzUK to offer MDISprint - bench to clinic MDI services Read More
PY 12/11/21 PY 12/11/21 Ab Initio's Chief Scientific Officer recognised for significant accomplishments within the field Read More
PY 11/25/21 PY 11/25/21 Learn how Ab Initio is helping start-ups translate therapeutics to the clinic Read More
PY 3/26/21 PY 3/26/21 Ab Initio continues to grow….meet our team! Ab Initio continues to grow….meet our team! Read More
Marcus Chan 2/12/21 Marcus Chan 2/12/21 Ab Initio Pharma wishes Everyone a Healthy, Happy & Prosperous Lunar New Year! Read More
Marcus Chan 1/29/21 Marcus Chan 1/29/21 Ab Initio Pharma partners with Consumer Healthcare Company VBreathe. Read More
PY 1/1/21 PY 1/1/21 Ab Initio Pharma wishes all its clients a COVID safe New Years Celebration and we look forward to working with you in 2021 Read More
Marcus Chan 7/9/20 Marcus Chan 7/9/20 University to spin out manufacturing pharmaceuticals company Read More